Methotrexate: role of treatment in skin disease.

Alex C. Holliday, Megan N. Moody, Alma Berlingeri-Ramos

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Methotrexate has been used for over half a century to treat a wide spectrum of skin conditions. It is a valuable steroid sparing agent, preventing protracted steroid courses and their undesirable side effects. While many alternative therapies exist and continue to emerge to treat these dermatologic conditions, the long history, affordability, and relative safety associated with methotrexate ensure its enduring utility. Further, ongoing research focusing on the pharmacogenetic properties of the drug may allow for more effective and targeted therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)4-9
Number of pages6
JournalSkin therapy letter
Volume18
Issue number3
StatePublished - Mar 2013

Fingerprint

Skin Diseases
Methotrexate
Steroids
Pharmacogenetics
Complementary Therapies
History
Safety
Skin
Therapeutics
Research
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Holliday, A. C., Moody, M. N., & Berlingeri-Ramos, A. (2013). Methotrexate: role of treatment in skin disease. Skin therapy letter, 18(3), 4-9.

Methotrexate : role of treatment in skin disease. / Holliday, Alex C.; Moody, Megan N.; Berlingeri-Ramos, Alma.

In: Skin therapy letter, Vol. 18, No. 3, 03.2013, p. 4-9.

Research output: Contribution to journalArticle

Holliday, AC, Moody, MN & Berlingeri-Ramos, A 2013, 'Methotrexate: role of treatment in skin disease.', Skin therapy letter, vol. 18, no. 3, pp. 4-9.
Holliday AC, Moody MN, Berlingeri-Ramos A. Methotrexate: role of treatment in skin disease. Skin therapy letter. 2013 Mar;18(3):4-9.
Holliday, Alex C. ; Moody, Megan N. ; Berlingeri-Ramos, Alma. / Methotrexate : role of treatment in skin disease. In: Skin therapy letter. 2013 ; Vol. 18, No. 3. pp. 4-9.
@article{fcf008b9f6044642952943f9d2a3bd1d,
title = "Methotrexate: role of treatment in skin disease.",
abstract = "Methotrexate has been used for over half a century to treat a wide spectrum of skin conditions. It is a valuable steroid sparing agent, preventing protracted steroid courses and their undesirable side effects. While many alternative therapies exist and continue to emerge to treat these dermatologic conditions, the long history, affordability, and relative safety associated with methotrexate ensure its enduring utility. Further, ongoing research focusing on the pharmacogenetic properties of the drug may allow for more effective and targeted therapeutic strategies.",
author = "Holliday, {Alex C.} and Moody, {Megan N.} and Alma Berlingeri-Ramos",
year = "2013",
month = "3",
language = "English (US)",
volume = "18",
pages = "4--9",
journal = "Skin therapy letter",
issn = "1201-5989",
publisher = "International Skin Therapy Newsletter, Inc.",
number = "3",

}

TY - JOUR

T1 - Methotrexate

T2 - role of treatment in skin disease.

AU - Holliday, Alex C.

AU - Moody, Megan N.

AU - Berlingeri-Ramos, Alma

PY - 2013/3

Y1 - 2013/3

N2 - Methotrexate has been used for over half a century to treat a wide spectrum of skin conditions. It is a valuable steroid sparing agent, preventing protracted steroid courses and their undesirable side effects. While many alternative therapies exist and continue to emerge to treat these dermatologic conditions, the long history, affordability, and relative safety associated with methotrexate ensure its enduring utility. Further, ongoing research focusing on the pharmacogenetic properties of the drug may allow for more effective and targeted therapeutic strategies.

AB - Methotrexate has been used for over half a century to treat a wide spectrum of skin conditions. It is a valuable steroid sparing agent, preventing protracted steroid courses and their undesirable side effects. While many alternative therapies exist and continue to emerge to treat these dermatologic conditions, the long history, affordability, and relative safety associated with methotrexate ensure its enduring utility. Further, ongoing research focusing on the pharmacogenetic properties of the drug may allow for more effective and targeted therapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=84887723479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887723479&partnerID=8YFLogxK

M3 - Article

C2 - 23674145

AN - SCOPUS:84887723479

VL - 18

SP - 4

EP - 9

JO - Skin therapy letter

JF - Skin therapy letter

SN - 1201-5989

IS - 3

ER -